Short answer: Gatsbie tracks 574 healthcare and medtech investors headquartered in Europe, and 110 of them are family offices. In Switzerland, 20 of the 54 healthcare and medtech investors are family offices, including INTERGROUP PARTNERS AG, Marcuard Family Office, WAYPOINT CAPITAL / FORESTAY CAPITAL, MASSELLAZ (4FO VENTURES) and MUTSCHLER VENTURES. (Gatsbie data as of 18 November 2026.)
Most medtech founders I talk to only pitch VCs. That's a mistake. Medical devices take years to get through regulation, and family offices can wait longer than a fund with a 10 year clock. Some of them made their money in healthcare and actually understand what a CE mark or an FDA 510(k) means for your timeline.
Why family offices fit medtech
- Patient capital. No fund cycle forcing an exit in 5 to 7 years.
- Flexible stages. Many write seed cheques and then follow on through growth.
- Networks. A family that built a pharma, hospital or distribution business can open doors to clinics and buyers, not just the next round.
The trade-off: family offices are harder to find, rarely have a public thesis page, and decide based on relationships. You need a warm path in.
Medtech family offices in Switzerland
Switzerland punches above its weight here. Of the 54 healthcare and medtech investors headquartered in Switzerland, most sit in Zurich (15), Geneva (11) and Zug (8). The most common stages are Seed (30), Series A (29) and Growth (26).
Family offices and family-backed investors on the list include:
| Investor | Based in | Stages | Focus includes |
|---|---|---|---|
| Marcuard Family Office | Zurich | Seed, Growth, Mature | Healthcare & MedTech, Financial Services, Consumer |
| INTERGROUP PARTNERS AG | Schindellegi | Seed, Series C+ | Hardware & IoT, Defense & Aerospace, Biotech |
| WAYPOINT CAPITAL / FORESTAY CAPITAL | Geneva | Series B, Series C+, Growth | Healthcare & MedTech, AI, Hardware & IoT |
MASSELLAZ (4FO VENTURES) and MUTSCHLER VENTURES are also on the list, with full profiles in Gatsbie.
If you're in biotech rather than devices, there's a separate list of 20 biotech and life sciences investors in Switzerland. 7 of them are family offices, including CC TRUST GROUP AG, SHILOH ADVISORS AG, 3T Family Office Ltd and Abegg & Co AG.
See all 54 in the healthcare and medtech investors in Switzerland list, or narrow to seed-stage medtech investors in Switzerland.
Medtech family offices across Europe
Across Europe, Gatsbie lists 574 healthcare and medtech investors. Most are in the United Kingdom (170), Germany (86) and France (54). 110 are family offices, including RINKELBERG CAPITAL, M4CAPITAL, Otium Capital, Alychlo and GESTIO CAPITAL (MATTEO MANFREDI).
The full list is on the healthcare and medtech investors in Europe page.
How to pitch a family office (what's different from a VC)
- Lead with risk, not just upside. Show your regulatory path, reimbursement plan and how much runway gets you to the next de-risking milestone.
- Get introduced. A cold email to a family office rarely works. Look for a shared school, a former colleague, or a founder they've already backed.
- Expect a slower first meeting and a faster close. There's no investment committee of ten people. Once the principal is convinced, things can move quickly.
- Ask what else they bring. Distribution, clinical partners, manufacturing. That's often worth more than the cheque.
Find the ones that fit you
A list of 110 is a starting point, not a shortlist. On Gatsbie, you upload your deck and the AI ranks every investor by fit, with a written reason for each, including family offices you've probably never heard of. It also drafts the outreach so you just review and send.
Written by Yen Tran, founder of Gatsbie. Data from Gatsbie's investor database, 18 November 2026.
